{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:53:18Z","timestamp":1781423598751,"version":"3.54.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik \u00dcniversitesi","doi-asserted-by":"publisher","award":["BAP04"],"award-info":[{"award-number":["BAP04"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik \u00dcniversitesi","doi-asserted-by":"publisher","award":["TAY-2022-10040"],"award-info":[{"award-number":["TAY-2022-10040"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005322","name":"Recep Tayyip Erdogan \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["121C188"],"award-info":[{"award-number":["121C188"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijbiomac.2025.139621","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:45:15Z","timestamp":1736876715000},"page":"139621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synthesis, biological evaluation and molecular docking studies of flavonol-3-O-\u03b2-D-glycoside as a potential inhibitor of SARS-CoV-2 main protease (3CLpro) in drug development for COVID-19"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4634-3354","authenticated-orcid":false,"given":"Gonca","family":"\u00c7elik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeng\u00fcl Alpay","family":"Karao\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeyma","family":"Suyabatmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Bozdeveci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem Tatar","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurettin","family":"Yayl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rah\u015fan","family":"Akp\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015feg\u00fcl \u00c7opur","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.139621_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134850","article-title":"Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics","volume":"278","author":"Jhanwar","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.139621_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0020","author":"WHO"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116389","article-title":"Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection","volume":"48","author":"Paulsson-Habegger","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0040","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/v13071270","article-title":"Modular evolution of coronavirus genomes","volume":"13","author":"Vakulenko","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.139621_bb0045","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/tbed.13872","article-title":"Potential zoonotic sources of SARS-CoV-2 infections","volume":"68","author":"Jo","year":"2020","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0050","article-title":"Clinical implications of a mechanistic link connecting SARS-Cov-2, diabetes mellitus, zinc in COVID-19 pathophysiology, and the prophylactics in the treatment of SARS-CoV-2","volume":"9","author":"Rout","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0055","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","article-title":"Review of the clinical characteristics of coronavirus disease 2019 (COVID-19)","volume":"35","author":"Jiang","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.139621_bb0060","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jemermed.2020.09.048","article-title":"Clinical features of patients with COVID-19: is temperature screening useful?","volume":"59","author":"Vilke","year":"2020","journal-title":"J. Emerg. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.139621_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257450","article-title":"Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection","volume":"16","author":"Nuertey","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115979","article-title":"Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: a strategy to tackle challenges of persistent virus infection","volume":"264","author":"Tian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.139621_bb0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jmii.2020.03.022","article-title":"Genotype and phenotype of COVID-19: their roles in pathogenesis","volume":"54","author":"Mousavizadeh","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.139621_bb0085","first-page":"306","article-title":"Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses, RSC","volume":"12","author":"Kumar","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115860","article-title":"Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors","volume":"29","author":"Amin","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116040","article-title":"Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking","volume":"33","author":"Vique-Sanchez","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.139621_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.139621_bb0105","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe COVID-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.139621_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106101","article-title":"Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19), facts, fiction, and hype: a critical appraisal","volume":"56","author":"Khuroo","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.139621_bb0115","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","volume":"6","author":"Cai","year":"2020","journal-title":"Engineering"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.139621_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11095-020-02799-8","article-title":"Tilorone: a broad-spectrum antiviral invented in the USA and commercialized in Russia and beyond","volume":"37","author":"Ekins","year":"2020","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.139621_bb0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jmv.26256","article-title":"Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"93","author":"Huang","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0130","article-title":"Some natural compounds and their analogues having potent anti-SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19","volume":"6","author":"Dinda","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0135","article-title":"Synthesis and photochemistry of flavonol camphorsulfonates photoinitiator with different substituents","volume":"183","author":"Li","year":"2023","journal-title":"Prog. Org. Coat."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0140","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1021\/acsomega.2c07245","article-title":"Camu Camu (Myrciaria dubia (Kunth) McVaugh): an Amazonian fruit with biofunctional properties\u2212a review","volume":"8","author":"Garcia-Chacon","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bpc.2014.01.003","article-title":"Exploring binding properties of naringenin with bovine \u03b2-lactoglobulin: a fluorescence, molecular docking and molecular dynamics simulation study","volume":"187-188","author":"Gholomi","year":"2014","journal-title":"Biophys. Chem."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.139621_bb0150","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1080\/07391102.2020.1805364","article-title":"Exploring 3-hydroxyflavone scaffolds as mushroom tyrosinase inhibitors: synthesis, X-ray crystallography, antimicrobial, fluorescence behaviour, structure-activity relationship and molecular modeling studies","volume":"39","author":"Ashraf","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2020.107759","article-title":"Identification and characterization of three flavonoid 3-Oglycosyltransferases from Epimedium koreanum Nakai","volume":"163","author":"Lyu","year":"2020","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128234","article-title":"Improvement of the oxidative stability of camelina oil by enrichment with phospholipid-quercetin formulations","volume":"341","author":"Garcia-Mendoza","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelechem.2020.114675","article-title":"Electrochemical study of quercetin in the presence of galactopyranose: potential application to the electrosynthesis of glycoconjugates of quinone\/quinone methide of quercetin","volume":"878","author":"Narog","year":"2020","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2021.108483","article-title":"Isolation, characterization and prediction of biologically active glycoside compounds quercetin-3-rutinoside from the fruits of Ficus sycomorus","volume":"511","author":"Al-Shabibi","year":"2022","journal-title":"Carbohydr. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.139621_bb0175","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1021\/acs.jnatprod.0c00869","article-title":"Phytochemical profiling and biological activity of the Australian carnivorous plant, Drosera magna","volume":"84","author":"Norman","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0180","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1016\/j.bmc.2006.09.014","article-title":"Binding interaction of quercetin-3-\u03b2-galactiside and its synthetic derivatives with SARS-CoV 3CLpro: structure-activity relationship studies reveal salient pharmacophore features","volume":"14","author":"Chen","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.139621_bb0185","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1080\/07391102.2020.1796799","article-title":"In-silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis","volume":"39","author":"Das","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0190","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3906\/kim-1501-112","article-title":"Synthesis and biological evaluation of a new series of 4-alkoxy-2-arylquinoline derivatives as potential antituberculosis agents","volume":"39","author":"Tosun","year":"2015","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0195","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1016\/j.tet.2017.06.064","article-title":"Synthesis of 5-substituted flavonols via the Algar-Flynn-Oyamada (AFO) reaction: the mechanistic implication","volume":"73","author":"Shen","year":"2017","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128458","article-title":"Design and synthesis of new flavonols as dual \u03b1-amylase and \u03b1-glucoside inhibitors: structure-activity relationship, drug-likeness, in-vitro and in-silico studies","volume":"1218","author":"Ashraf","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0205","first-page":"801","article-title":"Glucosylation of 4\u2032-hydroxychalcones using glucosyl donor","volume":"44","author":"Ingle","year":"2005","journal-title":"Indian J. Chem. Sect. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.139621_bb0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.55730\/1300-0527.3527","article-title":"Design, synthesis, and enzyme inhibition evaluation of some novel mono- and di-O-\u03b2-D-glycopyranosyl chalcone analogues with molecular docking studies","volume":"47","author":"\u00c7elik","year":"2023","journal-title":"Turk. J. Chem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.139621_bb0215","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/S0968-0896(03)00233-5","article-title":"Structure-activity relationships of antileishmanial and antimalarial chalcones","volume":"11","author":"Liu","year":"2003","journal-title":"Bioorg. Med. Chem."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.139621_bb0220","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.1021\/jm301376a","article-title":"Structure-activity relationships of targeted RuII(\u03b76-p-cymene) anticancer complexes with flavonol-derived ligands","volume":"55","author":"Kurzwernhart","year":"2012","journal-title":"J. Med. Chem."},{"issue":"38","key":"10.1016\/j.ijbiomac.2025.139621_bb0225","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1039\/D0OB01505A","article-title":"Influence of a 4\u2032-substituent on the efficiency of flavonol-based fluorescent indicators of \u03b2-glycosidase activity","volume":"18","author":"Reszka","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140490","article-title":"Synthesis, structural, spectroscopic (NMR, FT-IR and UV\u2013vis), NLO, in silico (ADMET and molecular docking) and DFT investigations of a flavonol derivative 2-(4-chlorophenyl)-7-fluoro-3-hydroxy-4H-chromen-4-one","volume":"1322","author":"\u00d6zt\u00fcrk","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0235","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1016\/j.bmc.2018.05.050","article-title":"Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors","volume":"26","author":"Mughal","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0240","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.phytol.2010.02.004","article-title":"Chalcone glycosides from aerial parts of Brassica rapa L. \u2018hidabeni\u2019, turnip","volume":"3","author":"Ninomiya","year":"2010","journal-title":"Phytochem. Lett."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.139621_bb0245","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1080\/07391102.2020.1803136","article-title":"Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure\u2013activity relationship and molecular modeling simulations","volume":"39","author":"Mughala","year":"2021","journal-title":"Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.139621_bb0250","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3906\/kim-2012-25","article-title":"Synthesis of Hydroxy benzoin\/Benzil analogs and investigation of their antioxidant, antimicrobial, enzyme inhibition, and cytotoxic activities","volume":"45","author":"Yayl\u0131","year":"2021","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2023.133733","article-title":"Design, synthesis and biological activity of coumarin-chalcone hybrid derivatives as phosphodiesterase type II (PDE2) inhibitors","volume":"149","author":"Zhu","year":"2023","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0260","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1016\/j.tet.2017.06.064","article-title":"Synthesis of 5-substituted flavonols via the Algar-Flynn-Oyamada (AFO) reaction: the mechanistic implication","volume":"73","author":"Shen","year":"2017","journal-title":"Tetrahedron"},{"issue":"9\u201310","key":"10.1016\/j.ijbiomac.2025.139621_bb0265","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/1747519820915165","article-title":"New chalcone-3-O-glycoside derivatives: synthesis and characterization","volume":"44","author":"\u00c7elik","year":"2020","journal-title":"J. Chem. Res."},{"issue":"7811","key":"10.1016\/j.ijbiomac.2025.139621_bb0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M pro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.139621_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0280","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0285","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mtphys.2019.02.003","article-title":"Two-dimensional black phosphorus: physical properties and applications","volume":"8","author":"Mu","year":"2019","journal-title":"Mater. Today Phys."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.139621_bb0290","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11094-023-02919-9","article-title":"Design, synthesis, biological activity and molecular docking studies of new imine-chalcone derivatives","volume":"57","author":"\u00c7elik","year":"2023","journal-title":"Pharm. Chem. J."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.139621_bb0295","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1016\/j.bmc.2014.08.038","article-title":"Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor","volume":"22","author":"Ma","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900292","article-title":"Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases","volume":"353","author":"\u00c7elik","year":"2020","journal-title":"Arch. Pharm."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.139621_bb0305","doi-asserted-by":"crossref","first-page":"15165","DOI":"10.1080\/07391102.2023.2227711","article-title":"Design, synthesis and anti-Tb evaluation of chalcone derivatives as novel inhibitors of InhA","volume":"41","author":"Dhivya","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.139621_bb0310","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1515\/pac-2016-0303","article-title":"An easy approach to dihydrochalcones via chalcone in situ hydrogenation","volume":"88","author":"Jesus","year":"2016","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0315","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/jccs.202300279","article-title":"Design, synthesis, and evaluation of 1,2,3-triazole-basedbenzenesulfonamide and flavonol hybrid molecules asanticancer agents","volume":"70","author":"Chen","year":"2023","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0320","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2013.04.064","article-title":"Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin","volume":"65","author":"Dias","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128458","article-title":"Design and synthesis of new flavonols as dual \u03b1-amylase and \u03b1-glucoside inhibitors: structure-activity relationship, drug-likeness, in-vitro and in-silico studies","volume":"1218","author":"Ashraf","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.139621_bb0330","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.139621_bb0335","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0959-440X(96)80061-3","article-title":"Computational methods for biomolecular docking","volume":"6","author":"Lengauer","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0340","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pro.3280","article-title":"Improvements to the APBS biomolecular solvation software suite","volume":"27","author":"Jurrus","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0345","series-title":"Molecular Cloning: A Laboratory Manual","volume":"Vol. 1","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0350","series-title":"Schr\u00f6dinger Release 2023\u20134 Desmond Molecular Dynamics System, Schrodinger LLC","author":"Schrodinger","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0355","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0360","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.139621_bb0365","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ffj.3636","article-title":"Biological activity, volatile and phenolic compounds from five Lamiaceae species, flavour","volume":"36","author":"\u00c7elik","year":"2021","journal-title":"Fragr. J."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0370","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201903770","article-title":"The manipulation of RNA-guided nucleic acid cleavage with ninhydrin chemistry","volume":"7","author":"Wang","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0375","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory InfectionsCaused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"ChemBioChem"},{"issue":"6489","key":"10.1016\/j.ijbiomac.2025.139621_bb0380","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0385","article-title":"An Open One-Step RT-qPCR for SARS-CoV-2 detection","author":"Cerda","year":"2023","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.139621_bb0390","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0022-2011(89)90099-2","article-title":"Structure of the nucleocapsid of a filamentous virus of the honey bee (Apis mellifera)","volume":"53","author":"Sitaropoulou","year":"1989","journal-title":"J. Invertebr. Pathol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.139621_bb0395","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/v7072798","article-title":"The Apis mellifera filamentous virus genome","volume":"9","author":"Gauthier","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.139621_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.epidem.2020.100392","article-title":"The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak","volume":"31","author":"Park","year":"2020","journal-title":"Epidemics"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025001709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025001709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:03:59Z","timestamp":1754427839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025001709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":79,"alternative-id":["S0141813025001709"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.139621","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, biological evaluation and molecular docking studies of flavonol-3-O-\u03b2-D-glycoside as a potential inhibitor of SARS-CoV-2 main protease (3CLpro) in drug development for COVID-19","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.139621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"139621"}}